Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 4Prostatic Neoplasms 3Neoplasm Metastasis 3Carcinoma, Non-Small-Cell Lung 3Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Advanced Solid Tumors 2Solid Tumor 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Rhabdoid Tumor 1Recurrence 1Neutropenia 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mesothelioma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Fever 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

pegfilgrastim 9Filgrastim 6eflapegrastim 3Docetaxel 3Cyclophosphamide 3posaconazole 1plerixafor 1isavuconazole 1ceftobiprole medocaril 1angiotensin I (1-7) 1Vancomycin 1Sodium Chloride 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Levofloxacin 1Itraconazole 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1EC regimen 1Daptomycin 1Cefepime 1Caspofungin 1Bevacizumab 1Algorithms 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neutropenia × Itraconazole × Clear all
NCT01021683 2013-08-12

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Janssen Korea, Ltd., Korea

Completed
203 enrolled 14 charts
Other hematologic neoplasm

Fever, Neutropenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡